News Digest / Ticker: PHIO

Ticker: PHIO

05:14pm, Thursday, Aug 14, 2025

Phio's PH-762 Shows Strong Responses, Cash Extended to Q2 2026 but Dilution Risks Loom

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Financials below are presented as in the company filing (amounts in thousands, unaudited). Quick take - what's happening inside: Phio is a clinical-stage immuno-oncology company focused on INTASYL siRNA candidates (PH-762 and PH-894). The company advance...